441 related articles for article (PubMed ID: 21778431)
1. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo.
Bos FL; Caunt M; Peterson-Maduro J; Planas-Paz L; Kowalski J; Karpanen T; van Impel A; Tong R; Ernst JA; Korving J; van Es JH; Lammert E; Duckers HJ; Schulte-Merker S
Circ Res; 2011 Aug; 109(5):486-91. PubMed ID: 21778431
[TBL] [Abstract][Full Text] [Related]
2. Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain.
Roukens MG; Peterson-Maduro J; Padberg Y; Jeltsch M; Leppänen VM; Bos FL; Alitalo K; Schulte-Merker S; Schulte D
Circ Res; 2015 May; 116(10):1660-9. PubMed ID: 25814692
[TBL] [Abstract][Full Text] [Related]
3. CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation.
Jeltsch M; Jha SK; Tvorogov D; Anisimov A; Leppänen VM; Holopainen T; Kivelä R; Ortega S; Kärpanen T; Alitalo K
Circulation; 2014 May; 129(19):1962-71. PubMed ID: 24552833
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.
Bui HM; Enis D; Robciuc MR; Nurmi HJ; Cohen J; Chen M; Yang Y; Dhillon V; Johnson K; Zhang H; Kirkpatrick R; Traxler E; Anisimov A; Alitalo K; Kahn ML
J Clin Invest; 2016 Jun; 126(6):2167-80. PubMed ID: 27159393
[TBL] [Abstract][Full Text] [Related]
5. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.
Jha SK; Rauniyar K; Karpanen T; Leppänen VM; Brouillard P; Vikkula M; Alitalo K; Jeltsch M
Sci Rep; 2017 Jul; 7(1):4916. PubMed ID: 28687807
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
[TBL] [Abstract][Full Text] [Related]
7. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
8. Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells.
Pan MR; Chang TM; Chang HC; Su JL; Wang HW; Hung WC
J Cell Sci; 2009 Sep; 122(Pt 18):3358-64. PubMed ID: 19706680
[TBL] [Abstract][Full Text] [Related]
9. A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy.
Hägerling R; Pollmann C; Andreas M; Schmidt C; Nurmi H; Adams RH; Alitalo K; Andresen V; Schulte-Merker S; Kiefer F
EMBO J; 2013 Mar; 32(5):629-44. PubMed ID: 23299940
[TBL] [Abstract][Full Text] [Related]
10. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
11. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
[TBL] [Abstract][Full Text] [Related]
12. Identification of targets of Prox1 during in vitro vascular differentiation from embryonic stem cells: functional roles of HoxD8 in lymphangiogenesis.
Harada K; Yamazaki T; Iwata C; Yoshimatsu Y; Sase H; Mishima K; Morishita Y; Hirashima M; Oike Y; Suda T; Miura N; Watabe T; Miyazono K
J Cell Sci; 2009 Nov; 122(Pt 21):3923-30. PubMed ID: 19825936
[TBL] [Abstract][Full Text] [Related]
13. Sox18 induces development of the lymphatic vasculature in mice.
François M; Caprini A; Hosking B; Orsenigo F; Wilhelm D; Browne C; Paavonen K; Karnezis T; Shayan R; Downes M; Davidson T; Tutt D; Cheah KS; Stacker SA; Muscat GE; Achen MG; Dejana E; Koopman P
Nature; 2008 Dec; 456(7222):643-7. PubMed ID: 18931657
[TBL] [Abstract][Full Text] [Related]
14. Emerging lymphae for the fountain of life.
Marchiò S; Astanina E; Bussolino F
EMBO J; 2013 Mar; 32(5):609-11. PubMed ID: 23361316
[TBL] [Abstract][Full Text] [Related]
15. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer.
Song J; Chen W; Cui X; Huang Z; Wen D; Yang Y; Yu W; Cui L; Liu CY
Theranostics; 2020; 10(5):2327-2341. PubMed ID: 32089745
[TBL] [Abstract][Full Text] [Related]
16. Development of the zebrafish lymphatic system requires VEGFC signaling.
Küchler AM; Gjini E; Peterson-Maduro J; Cancilla B; Wolburg H; Schulte-Merker S
Curr Biol; 2006 Jun; 16(12):1244-8. PubMed ID: 16782017
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
Saharinen P; Tammela T; Karkkainen MJ; Alitalo K
Trends Immunol; 2004 Jul; 25(7):387-95. PubMed ID: 15207507
[No Abstract] [Full Text] [Related]
18. The YAP-TEAD4 complex promotes tumor lymphangiogenesis by transcriptionally upregulating CCBE1 in colorectal cancer.
Song J; Dang X; Shen X; Liu Y; Gu J; Peng X; Huang Z; Hong W; Cui L; Liu CY
J Biol Chem; 2023 Apr; 299(4):103012. PubMed ID: 36781122
[TBL] [Abstract][Full Text] [Related]
19. The Lymphangiogenic Factor CCBE1 Promotes Angiogenesis and Tumor Growth in Colorectal Cancer.
Ding W; Tang W; Zhi J
Curr Mol Med; 2022; 22(9):819-825. PubMed ID: 34819004
[TBL] [Abstract][Full Text] [Related]
20. Visualization of lymphatic vessel development, growth, and function.
Pollmann C; Hägerling R; Kiefer F
Adv Anat Embryol Cell Biol; 2014; 214():167-86. PubMed ID: 24276894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
